Hello everyone,
Below is some recent news from Bio-IT World:
Qiagen Eyes Clinical NGS Market in Acquiring Intelligent Biosystems
Intelligent Biosystems (IBS), a privately held next-gen sequencing (NGS) company based in Waltham, Mass., has been acquired by molecular diagnostics company Qiagen, signaling a concerted move to integrate clinical NGS testing into the German company’s diagnostics portfolio. Read more
Below is some recent news from Bio-IT World:
Qiagen Eyes Clinical NGS Market in Acquiring Intelligent Biosystems
Intelligent Biosystems (IBS), a privately held next-gen sequencing (NGS) company based in Waltham, Mass., has been acquired by molecular diagnostics company Qiagen, signaling a concerted move to integrate clinical NGS testing into the German company’s diagnostics portfolio. Read more